Dr. Eric Bachelder Joins Advisory Board at Peptineo

Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Eric Bachelder, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Bachelder has joined the Peptineo Scientific Advisory Board. Dr. Bachelder is recognized as an emerging... - January 18, 2014 - Peptineo

Kimberley Beauford Joins Peptineo as Vice President of Human Capital

Industry veteran and accomplished executive, Kimberley Beauford has joined Peptineo as its new vice president of human capital. Beauford brings over 14 years of proven expertise in the delivery of innovative, strategic human capital programs to the finance and healthcare industries. Prior to... - January 14, 2014 - Peptineo

Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants

Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative Biomart

Kaygee Loparex India Pvt. Limited Awarded Integrated Management Systems (IMS) Certification by LRQA

Kaygee Loparex India, leading manufacturer of Silicone Coated Release Liner products has been awarded the prestigious IMS certification for demonstrating its commitment to Quality, Environment, and Occupational Health & Safety Management Systems. This certification has been awarded to the... - January 10, 2014 - Kaygee Loparex India Pvt Limited

Peptineo Inks Exclusive Option for Drug Delivery Technologies

Peptineo, a privately held biotechnology company, announced today that the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery. Under this agreement, Peptineo will work to commercialize drug delivery technologies developed in the laboratories... - December 10, 2013 - Peptineo

Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions

In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative Biomart

Creative Biomart Decides to Pump $300 Million to Strengthen Biosimilar Cell Lines Production

Today on the annual department meeting, Creative Biomart announces that it plans to invest more than $300 million to strengthen its biosimilar cell lines production in global range. The domain sectors of Creative Biomart are recombinant proteins, antibodies and enzymes. Several years ago, the... - November 17, 2013 - Creative Biomart

Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing

Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative Biomart

Creative Biomart Releases New Products in the Middle of Oct.

In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart

Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory

After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart

SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis

Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.

Creative Biomart is Going to Present Product Overview at Two Conferences

Creative Biomart announced today that Dr. Jane Lee, general product manager, will present product overview at two upcoming conferences. - September 11, 2013 - Creative Biomart

Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions

The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart

Creative Biomart Releases New Antibody Products—Nanobodies

Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart

Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody

In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative Biomart

Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay

There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart

Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users

In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative Biomart

Creative Biomart Launched Novel Animal-free Recombinant Proteins for Stable Research

The novel animal-free protein production system is more efficient, fast, flexible and cheap compared to transgenic plants recombinant proteins production; the scaling-up compared with bio-reactors is simple and lineal. It doesn't have issues with inclusion bodies as E.coli. - June 28, 2013 - Creative Biomart

NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics

NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics

Research results on the use of magnetic nanovectors for the tumor-specific localization of cancer therapeutics is discussed. - June 08, 2013 - NanCogenics Inc

Creative Biomart Scientists Found That Shutdown Gene Arih2 May Treat Hepatitis

Arih2 was found within the sentinel dendritic cells of the immune system, which play a vital role in defending intruders. - May 31, 2013 - Creative Biomart

Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D

Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative Biomart

GenScript Upgrade Free Bioinformatics Tools

GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers,as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.

GenScript Launches eBlot® Protein Transfer System

GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.

GenScript Launches New PolyExpress Package

With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.

ProteinSignal - A New Brand of GenScript, Focused on Protein Research

ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.

SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Cancer Institute (NCI) to develop novel and first-in-class agents in lung cancer. - October 03, 2012 - SignaBlok, Inc.

SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.

GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM

The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.

Nanocopoeia, an Innovative Leader in Particle-Based Therapeutics, is Pleased to Announce the Launch of Its Newly Redesigned Website

Nanocopoeia, Inc., a rapidly-growing nanotechnology company based in St. Paul, has launched its new corporate website, www.nanocopoeia.com. The new website provides detailed information on the applications and benefits of Nanocopoeia’s patented ElectroNanospray™ platform (ENS), a one... - June 01, 2012 - Nanocopoeia, Inc

Navinode to Launch World’s First All-Carbon Fibre Yacht at the Gold Coast Boat Show 2012 in Hong Kong

Navinode and Delta Powerboats will be launching the world’s first all-carbon fibre yacht in serial production in Asia at the Gold Coast Boat Show 2012 in Hong Kong. - April 01, 2012 - SHL Group (Scandinavian Health Group Ltd)

World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4

Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation

GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011

GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.

SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.

Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”

SHL is introducing the company’s first White Paper on autoinjectors with the goal of sharing with readers insights on how to prepare for the overall project. - January 05, 2012 - SHL Group (Scandinavian Health Group Ltd)

GenScript Launches Rush Gene Synthesis Service

Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in the global market. - December 27, 2011 - GenScript USA Inc.

GenScript Sponsors 2011 iGEM Undergraduate Synthetic Biology Competition

Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams they sponsored in 2011 iGEM undergraduate synthetic biology competition. The iGEM teams have utilized GenScript’s gene synthesis service to build novel... - December 17, 2011 - GenScript USA Inc.

SHL Receives Great Response at the 2011 PDA in Basel

SHL successfully wrapped exhibition at the PDA’s "The Universe of Pre-filled Syringes and Injection Devices” event. - December 14, 2011 - SHL Group (Scandinavian Health Group Ltd)

SHL to Speak and Exhibit at the 2011 PDA Conference in Basel, Switzerland

SHL will be exhibiting at the 2011 Parental Drug Association (PDA) Europe Conference in Basel, Switzerland November 8-9th at booth #44 & 49. - November 03, 2011 - SHL Group (Scandinavian Health Group Ltd)

SHL Receives Good Design Award for Molly Auto Injector

SHL Molly auto injector receives Good Design Award for its innovative design and related business model. - October 05, 2011 - SHL Group (Scandinavian Health Group Ltd)

Bencos Releases Bencos Shop Beta– Online Procurement System

Bencos Shop will enable all its users to place procurement requests for products & services for life sciences research. - September 12, 2011 - Bencos Research Solutions

Introducing an Optimized Process Management Concept from Drug Development to Drug Manufacturability: Advaceutics®

Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. - August 26, 2011 - ProJect Pharmaceutics GmbH

CannaLicense Has a New Corporate Office in Denver

The medical marijuana licensing center, Cannalicense has announced the opening of their new corporate office in Denver, Colorado. The new corporate office is located at 2250 S Oneida Street, Suite 306. This change is in response to the increase in applicants since the approval for medical marijuana... - August 19, 2011 - CannaLicense

CannaLicense Partners with KindReviews.com to Help Medical Marijuana Patients Learn About Efficacy and Strains

CannaLicense has just announced that they have partnered with KindReviews.com to help medical marijuana patients learn about efficacy and strains. Cannalicense is a medical marijuana licensing company that works with residents of Colorado and Arizona to get a license, to treat their illnesses and... - August 19, 2011 - CannaLicense

GenScript Launches Animal Model Services Worldwide

Internationally recognized biology contract research organization GenScript USA Inc. today announced that it has launched a broad spectrum of Animal Model Services for researchers to investigate the efficacy and safety profile of drug candidates. The services include in vivo drug efficacy,... - August 10, 2011 - GenScript USA Inc.

Bencos Shifts Website Domain from .in to .com

Bencos Research Solutions Pvt. Ltd. is now available at www.bencoslife.com. - August 09, 2011 - Bencos Research Solutions

SHL to Speak and Exhibit at the World Drug Delivery Congress 2011

SHL will speak and exhibit at the upcoming Drug Delivery Congress in Singapore from September 5-6th. - August 05, 2011 - SHL Group (Scandinavian Health Group Ltd)

Introducing SHL Pharma: a Greener Approach

SHL Pharma is SHL's newest facility in Florida, USA offering final assembly, labeling and packaging for drug delivery devices and has been constructed with LEED practices. - July 01, 2011 - SHL Group (Scandinavian Health Group Ltd)

Synvir's Ultrafast Nozzle Speeds Past T-Junction Chips

A new MEMs nozzle produces 100,000 microdroplets per second. - May 31, 2011 - Synvir, Inc.

Cannalicense Recently Expanded Into Arizona and is Already Getting Patients Legal in Phoenix

Cannalicense has recently expanded their services into Arizona, and is already getting patients legal in Phoenix, for the use of medical marijuana. The service provides patients with the steps necessary toward obtaining a medical marijuana card, for the legal use of the plant, for medical... - May 26, 2011 - CannaLicense

The PhaSeal® System Helps Comply with New Legislation

Using PhaSeal Contributes to a Reduced Exposure Potential for Healthcare Workers - May 19, 2011 - Carmel Pharma

Press Releases 101 - 150 of 226